Floatz logo

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE

Acute Pain

The Second Affiliated Hospital of Chongqing Medical UniversitySmall moleculePhase 4 / ApprovedActive
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Acute Pain cohort.

Asset / SponsorPhaseRating
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Tanta University
Phase 4BBB
NEPENTHE
Ondokuz Mayıs University
Phase 4BBB
DEXAMETHASONE
Peking University Third Hospital
Phase 4BB
LIDOCAINE
Peking University Third Hospital
Phase 4BB
MIVACURIUM ION
VA Pittsburgh Healthcare System
Phase 4BB

View all 31 →

Same molecule, other indications

(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:

Pain, PostoperativeDormant
BBB
Indicative ·
78 / 100
View asset →
Anesthesia, LocalDormant
BBB
Indicative ·
76 / 100
View asset →
neuralgiaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →